ATE279521T1 - Regulierende nukleinsaeuresequenzen und verwendungen - Google Patents

Regulierende nukleinsaeuresequenzen und verwendungen

Info

Publication number
ATE279521T1
ATE279521T1 AT95902830T AT95902830T ATE279521T1 AT E279521 T1 ATE279521 T1 AT E279521T1 AT 95902830 T AT95902830 T AT 95902830T AT 95902830 T AT95902830 T AT 95902830T AT E279521 T1 ATE279521 T1 AT E279521T1
Authority
AT
Austria
Prior art keywords
acid sequences
pct
regulatory
nuclic acid
date jun
Prior art date
Application number
AT95902830T
Other languages
English (en)
Inventor
Annick Friedmann
Michel Guerineau
Juliette Hagege
Jean-Luc Pernodet
Guennady Sezonov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE279521T1 publication Critical patent/ATE279521T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95902830T 1993-12-08 1994-12-05 Regulierende nukleinsaeuresequenzen und verwendungen ATE279521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9314701A FR2713658B1 (fr) 1993-12-08 1993-12-08 Séquences d'acides nucléiques régulatrices et utilisations.
PCT/FR1994/001413 WO1995016046A1 (fr) 1993-12-08 1994-12-05 Sequences d'acides nucleiques regulatrices et utilisations

Publications (1)

Publication Number Publication Date
ATE279521T1 true ATE279521T1 (de) 2004-10-15

Family

ID=9453681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902830T ATE279521T1 (de) 1993-12-08 1994-12-05 Regulierende nukleinsaeuresequenzen und verwendungen

Country Status (15)

Country Link
US (1) US5741675A (de)
EP (1) EP0788549B1 (de)
JP (1) JP3751019B2 (de)
KR (1) KR100367753B1 (de)
AT (1) ATE279521T1 (de)
AU (1) AU686707B2 (de)
CA (1) CA2177600C (de)
DE (1) DE69434072T2 (de)
DK (1) DK0788549T3 (de)
ES (1) ES2229230T3 (de)
FR (1) FR2713658B1 (de)
NZ (1) NZ277049A (de)
PT (1) PT788549E (de)
WO (1) WO1995016046A1 (de)
ZA (1) ZA949807B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861513B2 (en) * 2000-01-12 2005-03-01 Schering Corporation Everninomicin biosynthetic genes
WO2001075116A2 (en) * 2000-04-04 2001-10-11 Schering Corporation ISOLATED NUCLEIC ACIDS FROM MICROMONOSPORA ROSARIA PLASMID pMR2 AND VECTORS MADE THEREFROM
WO2001087936A2 (en) * 2000-05-17 2001-11-22 Schering Corporation Isolation of micromonospora carbonacea var africana pmlp1 integrase and use of integrating function for site-specific integration into micromonospora halophitica and micromonospora carbonacea chromosome
TW201118170A (en) * 2009-11-20 2011-06-01 Ind Tech Res Inst Expression vector for expressing recombinant protein in cyanobacterium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR350341A (fr) * 1904-11-24 1906-01-12 Louis Boisard Système de taille des vis globiques
FR2631634B1 (fr) * 1988-05-18 1991-06-14 Centre Nat Rech Scient Vecteurs de clonage et d'expression dans une souche d'actinomycete, procede de transformation de cette souche, souche d'actynomycete obtenue et preparation de proteines
US5098837A (en) * 1988-06-07 1992-03-24 Eli Lilly And Company Macrolide biosynthetic genes for use in streptomyces and other organisms
FR2696189B1 (fr) * 1992-09-25 1994-11-10 Rhone Poulenc Rorer Sa Polypeptides impliqués dans la biosynthèse des streptogramines, séquences nucléotidiques codant pour ces polypeptides et leur utilisation.

Also Published As

Publication number Publication date
PT788549E (pt) 2005-01-31
AU686707B2 (en) 1998-02-12
EP0788549A1 (de) 1997-08-13
JP3751019B2 (ja) 2006-03-01
JPH09506257A (ja) 1997-06-24
US5741675A (en) 1998-04-21
FR2713658A1 (fr) 1995-06-16
DE69434072D1 (de) 2004-11-18
CA2177600A1 (fr) 1995-06-15
EP0788549B1 (de) 2004-10-13
DE69434072T2 (de) 2005-11-17
DK0788549T3 (da) 2005-02-14
ZA949807B (en) 1996-04-01
CA2177600C (fr) 2009-02-03
KR100367753B1 (ko) 2003-12-31
FR2713658B1 (fr) 1996-04-12
AU1193595A (en) 1995-06-27
NZ277049A (en) 1997-09-22
ES2229230T3 (es) 2005-04-16
WO1995016046A1 (fr) 1995-06-15

Similar Documents

Publication Publication Date Title
RU94036748A (ru) Церамиды, способ их получения, композиция на их основе и способ гидратирующей обработки кожи или волос
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
DE69401581D1 (de) Partikelförmiges vektor und pharmazeutische zusammensetzung die diese enthält
BR8901711A (pt) Aperfeicoamento no processo para a polimerizacao em leito fluido de alfaolefinas
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE69619114D1 (de) Pyrolopyrimidine und verfahren zu ihrer herstellung
ATE204164T1 (de) Pflaster zur behandlung von nagelmykosen
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE69818450D1 (de) Im wesentlichen reines zonulin als physiologischer modulator von "tight junctions" bei säugern
ATE216428T1 (de) In yarrowia funktionell aktive stromaufwärts- liegende aktivatorsequenzen und rekombinante promotersequenzen und vektoren die diese enthalten
ZA944303B (en) Nucleic acid sequences vectors containing them pharmaceutical compositions and therapeutic uses
IT1251203B (it) Procedimento e apparecchiatura per la fermentazione di amminoacidi
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
ATE279521T1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
AU6378994A (en) Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
AU3347293A (en) Expression signal-peptide-free staphylokinases
ATE194360T1 (de) Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
ATE328088T1 (de) Transketolase-verwandtes protein
PL309339A1 (en) Novel triazoquinazolines, methods of obtaining them and their application

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0788549

Country of ref document: EP